MR lymphangiography (MRL) utilizing the clinically available small molecular weight gadolinium contrast agents suffers from diffusion of contrast out of the lymphatic system and into the blood pool. We describe a modified MRL technique where a clinically available iron oxide nanoparticle (ferumoxytol) is used as the lymphatic contrast agent. The higher molecular weight of these nanoparticles results in retention of contrast within the lymphatic system. This simplifies peripheral lymphatic imaging by eliminating the need for vascular contamination suppression techniques and should allow better tracking of contrast through the central lymphatics following pedal injections.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords